Antipsychotic Prescribing and Delirium Outcomes at a Mexican Tertiary Referral Center: A Retrospective Cohort

Background: Haloperidol remains the default antipsychotic for hospital delirium in much of the world, yet prescribing practice and measured outcomes have rarely been described together in Latin American hospitals. Methods: Retrospective cohort of consecutive adults with delirium seen by consultation-liaison psychiatry at a Mexico City tertiary referral centre (March 2021 to August 2022). Severity was the summed CAM-S short-form score (0–7) at each psychiatric visit; each patient contributed one index antipsychotic regimen. We modelled CAM-S with linear mixed models and estimated cumulative incidence of first resolution (CAM-S = 0) with the Aalen–Johansen estimator, treating in-hospital death as a competing event. No comparative-effectiveness hypothesis was prespecified. Results: Of 195 screened records, 136 patients contributing 724 assessments were analysed; haloperidol accounted for 115 regimens (84.6%). CAM-S fell by 0.38 points per day (95% CI 0.30–0.45; p < 0.001), from 3.79 to 2.21. Adjusted for baseline severity, no agent differed from haloperidol (olanzapine −0.50, 95% CI −1.04 to 0.05; risperidone −0.23, −0.69 to 0.24). Cumulative incidence of first resolution reached 38.3% (95% CI 27.1–49.4) by day 7 and 46.1% (31.8–59.2) by day 14. Baseline CAM-S was the only variable associated with resolution (hazard ratio 0.49 per point, 0.36–0.67). Physician-documented improvement at discharge (77.9%) far exceeded instrument-based severity control (25.0%). Conclusions: Prescribing was concentrated on haloperidol while measured severity improved independently of which agent was chosen. The gap between charted improvement and measured outcomes reflects two different constructs, not a treatment effect. These data describe local practice and cannot support causal comparison between agents.

Authors

Institutions

Publication Details

Journal
Clinical Pharmacy Connect
Published
2026-11-18
DOI
https://doi.org/10.69709/cpc.2026.120064
Primary Topic
Intensive Care Unit Cognitive Disorders
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Antipsychotic Prescribing and Delirium Outcomes at a Mexican Tertiary Referral Center: A Retrospective Cohort

Martha Georgina Ochoa Madrigal, Óscar Meneses Luna, Deldhy Nicolas Moya-Sánchez, Alejandro Salazar-Rodríguez et al.
1 links
Clinical Pharmacy Connect
Intensive Care Unit Cognitive Disorders
article

Antipsychotic Prescribing and Delirium Outcomes at a Mexican Tertiary Referral Center: A Retrospective Cohort

Martha Georgina Ochoa Madrigal, Óscar Meneses Luna, Deldhy Nicolas Moya-Sánchez, Alejandro Salazar-Rodríguez, Francisco Javier Cruz Aviña, Alejandro Díaz-Bernal, Elia Francisca Espinoza-de-Ávila
article en

Abstract

Background: Haloperidol remains the default antipsychotic for hospital delirium in much of the world, yet prescribing practice and measured outcomes have rarely been described together in Latin American hospitals. Methods: Retrospective cohort of consecutive adults with delirium seen by consultation-liaison psychiatry at a Mexico City tertiary referral centre (March 2021 to August 2022). Severity was the summed CAM-S short-form score (0–7) at each psychiatric visit; each patient contributed one index antipsychotic regimen. We modelled CAM-S with linear mixed models and estimated cumulative incidence of first resolution (CAM-S = 0) with the Aalen–Johansen estimator, treating in-hospital death as a competing event. No comparative-effectiveness hypothesis was prespecified. Results: Of 195 screened records, 136 patients contributing 724 assessments were analysed; haloperidol accounted for 115 regimens (84.6%). CAM-S fell by 0.38 points per day (95% CI 0.30–0.45; p < 0.001), from 3.79 to 2.21. Adjusted for baseline severity, no agent differed from haloperidol (olanzapine −0.50, 95% CI −1.04 to 0.05; risperidone −0.23, −0.69 to 0.24). Cumulative incidence of first resolution reached 38.3% (95% CI 27.1–49.4) by day 7 and 46.1% (31.8–59.2) by day 14. Baseline CAM-S was the only variable associated with resolution (hazard ratio 0.49 per point, 0.36–0.67). Physician-documented improvement at discharge (77.9%) far exceeded instrument-based severity control (25.0%). Conclusions: Prescribing was concentrated on haloperidol while measured severity improved independently of which agent was chosen. The gap between charted improvement and measured outcomes reflects two different constructs, not a treatment effect. These data describe local practice and cannot support causal comparison between agents.

Clinical Pharmacy Connect
Institute for Social Security and Services for State Workers (MX), Universidad Nacional Autónoma de México (MX)
Instituto de Seguriidad y Servicios Sociales de los Trabadores del Estado
Good health and well-being
Intensive Care Unit Cognitive Disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon